News
Screening for ovarian cancer is ruled out after trial found it did not reduce deaths
BMJ 2021; 373 doi: https://doi.org/10.1136/bmj.n1223 (Published 12 May 2021) Cite this as: BMJ 2021;373:n1223- Nikki Nabavi
- The BMJ
A large trial of annual screening tests for ovarian cancer showed they did not reduce deaths despite picking up cancers earlier,1 ruling out the possibility of a national population screening programme.
The UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), led by UCL researchers, looked at data from more than 200 000 women who were aged 50-74, and followed them up for an average of 16 years. The women were randomly allocated to one of three groups: no screening, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.